Clinical Trials Browser

Phase 2 × Hodgkin Disease × iratumumab × Clear all

NCT00284804 2015-10-12

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

Phase 2 Completed

Hodgkin Disease, Recurrence